NBIX quarterly revenue hits $1 billion on Ingrezza, CRENESSITY strength
NBIX reported quarterly revenue of $1 billion, supported by growth in Ingrezza, CRENESSITY and VYKAT XR. The company cited outperforming Ingrezza and CRENESSITY expectations plus pipeline catalysts and commercial initiatives for future expansion.
Quarterly revenue reached $1 billion, driven by strong growth in Ingrezza, CRENESSITY, and VYKAT XR, with robust financial flexibility and a clean balance sheet. Ingrezza and CRENESSITY continue to outperform expectations, while pipeline catalysts and commercial initiatives are set to drive future…